Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02161627 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness of Spinal Cord Stimulation With Automatic Control to Treat Chronic Pain in an Extended Trial

A NA study, sponsored by Saluda Medical Pty.

Completed
Registry status
NA
Development phase
69
Enrollment target

NCT02161627: Completed NA study, sponsored by Saluda Medical Pty.

NCT02161627 is a NA study that has completed, run by Saluda Medical Pty. The registered enrollment target is 69 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02161627, a NA study, has completed, sponsored by Saluda Medical Pty.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target

Study Summary

The aims of the study are to compare automatic control of spinal cord stimulation with manual control in patients with chronic pain of the trunk and limbs

Primary Outcome

After subjects experience both automatic and manual control after 20 days, subjects are asked to compare pain relief and stimulation side effects between the two arms of the study (blinded) in two separate domains using two 5-point Likert scales. The outcome measure for the primary objective is the percentage of subjects who report improved pain relief with no worsening of stimulation side-effects or improved stimulation side-effects with no loss of pain relief during the automatic control arm r

Interventions

  • DEVICE Saluda Medical External Trial System

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2014-07
Est. Completion 2015-05
Phase NA
Saluda Medical Pty

4 total trials

What the finished NCT02161627 record still lists

NCT02161627 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Saluda Medical External Trial System is the first listed.

NCT02161627 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02161627 about?

NCT02161627 is a clinical study titled "Safety and Effectiveness of Spinal Cord Stimulation With Automatic Control to Treat Chronic Pain in an Extended Trial". The aims of the study are to compare automatic control of spinal cord stimulation with manual control in patients with chronic pain of the trunk and limbs

What is the current status of trial NCT02161627?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2014-07. Estimated completion is 2015-05.

What interventions are being tested in trial NCT02161627?

The interventions under investigation include: Saluda Medical External Trial System (DEVICE).

Who is sponsoring clinical trial NCT02161627?

This trial is sponsored by Saluda Medical Pty, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02161627's enrollment target sits among peer trials

69 1133rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02161627, the US trial registry maintained by the National Library of Medicine. NCT02161627 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.